Contact Us
BioVista’s AI-powered, patent-pending diagnostic platform redefines care for liver and kidney patients—bringing results comparable to CT Scanners using harmless Ultrasound technology. By reducing costs by up to 90% and removing the burden of travel, it ensures access for even the most underserved communities.
With guided scans performed remotely, specialists can now be provided with insights, enabling early detection and faster treatment. From rural villages to advanced hospitals, this ultra-portable solution bridges critical gaps in healthcare—offering a new standard of affordability, mobility, and clinical precision.
It’s not just technology—it’s hope, access, and a healthier future for millions
A medical diagnostics company focused on AI-powered ultrasound imaging.
Mission: Make liver disease detection affordable, accessible, and radiation-free.
Developed an Ultrasound Visualization & Diagnostic System that integrates AI for precision, speed, and ease of use.
90% cost savings
– Remote and AI-enabled solutions drastically cut costs on equipment, scans, and in-person infrastructure.
Higher margins
– With lower operating costs and optimized workflows, hospitals can increase profitability while still offering affordable services.
Easy staffing
– Remote tools allow specialists to serve multiple facilities without being physically present, reducing staffing shortages and costs.
AI-assisted accuracy
– Diagnostic AI helps identify patterns and early-stage conditions that may be missed in manual review, improving reliability.
Patient history tracking
– Centralized digital records make it easier to follow a patient’s progress and tailor treatment plans.
Remote patient monitoring (RPM)
– Continuous tracking of vital signs and health metrics enables proactive care, catching problems before they escalate.
More patients served
– Automation and remote consultations reduce bottlenecks, letting doctors expand reach to underserved areas or larger patient bases.
Affordable
– Remote diagnostics eliminate frequent hospital visits and expensive scans, making healthcare more budget-friendly for patients.
Faster diagnosis
– With AI and telemedicine tools, results are processed more quickly, reducing waiting times and enabling earlier treatment.
No atomic radiation
– Safer alternatives to traditional imaging (like CT scans) protect patients from long-term radiation risks.
Home/nearby access – Patients can access care from home or at local clinics, minimizing travel, waiting lines, and time off work.
Reduce liver transplant needs
– Earlier detection and monitoring reduce the progression of liver disease, lowering demand for costly transplants.
Rural access
– Telemedicine bridges the healthcare gap in rural or remote regions, providing advanced diagnostics without the need for travel.
Lower mortality
– Faster diagnoses and accessible treatment options decrease preventable deaths, improving overall public health outcomes.
No. Ultrasound imaging emits very high frequency (non-audible) sound waves into the body and the captures the reflections. Ultrasound scanning is considered as one of the safest medical imaging when compared with X-ray or CT scans which uses atomic radiation.
We are looking for partners who are interested in contributing to our research programs intellectually or financially. We are also interested in getting in touch with possible business partners who are interested in making profit from the complete biovista diagnostics solution or the proprietary IP components. Come talk to us!